This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The University of Chicago. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: The Innovative Contributions of Hilary Kenny
Introduction
Hilary Kenny is a notable inventor based in Chicago, IL (US). He has made significant contributions to the field of medical research, particularly in the treatment of ovarian cancer. His work focuses on innovative methods that aim to improve patient outcomes through targeted therapies.
Latest Patents
Hilary Kenny holds a patent for "Methods for treating ovarian cancer by inhibiting fatty acid binding proteins." This invention concerns methods and compositions for the inhibition or reduction of the primary tumor and metastasis by inhibiting fatty acid binding proteins. His research is pivotal in advancing treatment options for ovarian cancer patients.
Career Highlights
Kenny is affiliated with The University of Chicago, where he conducts his research and develops his innovative ideas. His work has garnered attention for its potential impact on cancer treatment and patient care.
Collaborations
Hilary Kenny collaborates with esteemed colleagues such as Ernst Lengyel and Kristin Nieman. These partnerships enhance the research efforts and contribute to the development of effective cancer therapies.
Conclusion
Hilary Kenny's contributions to the field of cancer research exemplify the importance of innovation in medicine. His patent and collaborative efforts reflect a commitment to improving treatment options for ovarian cancer patients.